To provide long-term capital growth by investing in a portfolio of life science companies where innovation plays a crucial role in improving global health and economic outcomes.
Objective
Growth
Asset Class
Shares/Equity
Min. Investment
$25,000
Liquidity
Illiquid
Industry
Diversified
Availability
Open for investment
Funding Stage
Unlisted Early-Stage Fund
Structure
Managed Fund